Not Tagged
Not Tagged
['sclc']
patients with slfn11-expressing sclc may benefit from immune checkpoint inhibitor plus parp inhibitor - the asco post 
A Board Certified medical Oncologist with focuses on Lung Cancer Clinical, Translational Research & Phase I Clinical Trials.